Is serputinib/serpatinib effective in treating thyroid cancer?

Selpercatinib (Selpercatinib) is a targeted therapy used to treat thyroid cancer patients with specific genetic mutations. This drug is mainly used to treat thyroid cancer related to RET gene mutations. The main mechanism of action of seputinib is to inhibit the activation of RET protein, thereby blocking tumor growth and spread. This makes seputinib an effective drug option for the treatment of RET gene-mutated thyroid cancer.

According to clinical trials and research results, seputinib has shown significant efficacy in the treatment of thyroid cancer. In a study of patients with advanced or metastatic RET-mutant thyroid cancer, more than half of the patients experienced tumor shrinkage after treatment with seputinib. In addition, many patients experienced prolonged stabilization. Each patient's situation is unique and the effectiveness of treatment may vary based on individual differences. In addition, seputinib may cause some side effects, such as high blood pressure, fatigue, nausea, etc. Therefore, before using this drug, doctors will evaluate the appropriateness of treatment, taking into account the patient's condition and overall health.

Up to now, the original drug is sold in China as Seputinib, but it is not included in medical insurance. The price of each box of specifications80mg*56 capsules may be more than 10,000 yuan. There are European and American versions of the original drugs sold overseas, with the price of each box ranging from 20,000 to more than 100,000 yuan (prices may fluctuate due to exchange rates). Seputinib is also available overseasSeputinibGeneric drugs are on the market, and their drug ingredients are basically the same as those of original drugs sold domestically and abroad. For example, the specifications produced by Laos Pharmaceutical Factory40mg*120 pills per box are more than 4,000 yuan (the price may fluctuate due to the exchange rate).